Search research articles
Contact Us
Filters
Showing results (1-10 of 36) with videos related to
Page
of 4
Sort By:
Cytotechnology
|
November 13, 2008
Equipment design considerations for large scale cell culture
David M Marks
The Primary Care Companion for CNS Disorders
|
February 3, 2016
Durability of Benefit From Repeated Intravenous Lidocaine Infusions in Fibromyalgia Patients: A Case Series and Literature Review
David M Marks, Amy Newhouse
The Primary Care Companion for CNS Disorders
|
January 7, 2014
Open-label milnacipran for patients with persistent knee pain 1 year or longer after total knee arthroplasty: a pilot study
David M Marks, Michael P Bolognesi
Psychiatry Investigation
|
January 5, 2010
Innovations in clinical research design and conduct in psychiatry: shifting to pragmatic approaches
David M Marks, Thanaseelan J, Chi-Un Pae
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 27, 2009
Safety and antipsychotic efficacy of "forced" intramuscular olanzapine over five days: a case report
David M Marks, Matthew J Conner, Chi-Un Pae
Current Neuropharmacology
|
July 10, 2009
Triple reuptake inhibitors: the next generation of antidepressants
David M Marks, Chi-Un Pae, Ashwin A Patkar
Psychiatry Investigation
|
January 5, 2010
Triple reuptake inhibitors: a premise and promise
David M Marks, Chi-Un Pae, Ashwin A Patkar
The International Journal of Neuropsychopharmacology
|
April 9, 2008
Potential role of pregabalin in the treatment of lithium-induced tremor: a case report
David M Marks, Chi-Un Pae, Ashwin A Patkar
The Primary Care Companion for CNS Disorders
|
February 10, 2015
A double-blind, placebo-controlled, parallel-group pilot study of milnacipran for chronic radicular pain (sciatica) associated with lumbosacral disc disease
David M Marks, Chi-Un Pae, Ashwin A Patkar
Journal of Psychiatric Research
|
April 24, 2012
Concerns about data reporting and interpretation in "Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial"
David M Marks, Jonathan S Abramowitz, Glen I Spielmans
Page
of 4
Search research articles
Search
Showing results (1-10 of 36) with videos related to
Sort By:
Page
of 4
Cytotechnology
|
November 13, 2008
Equipment design considerations for large scale cell culture
David M Marks
The Primary Care Companion for CNS Disorders
|
February 3, 2016
Durability of Benefit From Repeated Intravenous Lidocaine Infusions in Fibromyalgia Patients: A Case Series and Literature Review
David M Marks, Amy Newhouse
The Primary Care Companion for CNS Disorders
|
January 7, 2014
Open-label milnacipran for patients with persistent knee pain 1 year or longer after total knee arthroplasty: a pilot study
David M Marks, Michael P Bolognesi
Psychiatry Investigation
|
January 5, 2010
Innovations in clinical research design and conduct in psychiatry: shifting to pragmatic approaches
David M Marks, Thanaseelan J, Chi-Un Pae
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 27, 2009
Safety and antipsychotic efficacy of "forced" intramuscular olanzapine over five days: a case report
David M Marks, Matthew J Conner, Chi-Un Pae
Current Neuropharmacology
|
July 10, 2009
Triple reuptake inhibitors: the next generation of antidepressants
David M Marks, Chi-Un Pae, Ashwin A Patkar
Psychiatry Investigation
|
January 5, 2010
Triple reuptake inhibitors: a premise and promise
David M Marks, Chi-Un Pae, Ashwin A Patkar
The International Journal of Neuropsychopharmacology
|
April 9, 2008
Potential role of pregabalin in the treatment of lithium-induced tremor: a case report
David M Marks, Chi-Un Pae, Ashwin A Patkar
The Primary Care Companion for CNS Disorders
|
February 10, 2015
A double-blind, placebo-controlled, parallel-group pilot study of milnacipran for chronic radicular pain (sciatica) associated with lumbosacral disc disease
David M Marks, Chi-Un Pae, Ashwin A Patkar
Journal of Psychiatric Research
|
April 24, 2012
Concerns about data reporting and interpretation in "Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial"
David M Marks, Jonathan S Abramowitz, Glen I Spielmans
Page
of 4